KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Depreciation & Amortization - TotalEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Non-Controlling InterestsInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

National Health Investors (NHI) Revenue (2016 - 2026)

National Health Investors filings provide 18 years of Revenue readings, the most recent being $115.1 million for Q1 2026.

  • On a quarterly basis, Revenue rose 28.93% to $115.1 million in Q1 2026 year-over-year; TTM through Mar 2026 was $256.3 million, a 26.77% increase, with the full-year FY2025 number at $375.6 million, up 12.07% from a year prior.
  • Revenue hit $115.1 million in Q1 2026 for National Health Investors, up from $105.8 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $115.1 million in Q1 2026 to a low of -$171.7 million in Q4 2022.
  • Median Revenue over the past 5 years was $21.2 million (2025), compared with a mean of $38.2 million.
  • Biggest five-year swings in Revenue: plummeted 83.87% in 2022 and later soared 146.27% in 2023.
  • National Health Investors' Revenue stood at -$171.7 million in 2022, then soared by 146.27% to $79.5 million in 2023, then grew by 7.92% to $85.8 million in 2024, then rose by 23.4% to $105.8 million in 2025, then grew by 8.79% to $115.1 million in 2026.
  • The last three reported values for Revenue were $115.1 million (Q1 2026), $105.8 million (Q4 2025), and $21.2 million (Q3 2025) per Business Quant data.